Intrathecal Trastuzumab Halts Progression of CNS Metastases in Breast Cancer

被引:32
作者
Bousquet, Guilhem [1 ,2 ,3 ]
Darrouzain, Francois [4 ,5 ,6 ]
de Bazelaire, Cedric [1 ,2 ,3 ]
Ternant, David [4 ,5 ,6 ]
Barranger, Emmanuel [1 ,7 ]
Winterman, Sabine [8 ]
Madelaine-Chambin, Isabelle [7 ]
Thiebaut, Jean-Baptiste [9 ]
Polivka, Marc [3 ]
Paintaud, Gilles [4 ,5 ,6 ]
Culine, Stephane [1 ,3 ]
Janin, Anne [1 ,2 ,3 ]
机构
[1] Univ Paris Diderot, UMR S728, Paris, France
[2] INSERM, U728, Paris, France
[3] Hop St Louis, AP HP, Paris, France
[4] Univ Tours, Tours, France
[5] CNRS, UMR 7292, Tours, France
[6] CHR Univ Tours, Tours, France
[7] Hop Lariboisiere, AP HP, F-75475 Paris, France
[8] Hop Avicenne, AP HP, Paris, France
[9] Fdn Ophtalmol Rothschild, Paris, France
关键词
BLOOD-BRAIN-BARRIER; PHARMACOKINETIC ANALYSIS; MACULAR DEGENERATION; MONOCLONAL-ANTIBODY; PIGLET MODEL; AGE; 4TH-VENTRICLE; SAFETY;
D O I
10.1200/JCO.2012.44.8894
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:E151 / E155
页数:5
相关论文
共 14 条
[1]   Pharmacokinetics, safety, and efficacy of trastuzumab administered every three weeks in combination with paclitaxel [J].
Leyland-Jones, B ;
Gelmon, K ;
Ayoub, JP ;
Arnold, A ;
Verma, S ;
Dias, R ;
Ghahramani, P .
JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (21) :3965-3971
[2]   Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer and Central Nervous System Metastases [J].
Leyland-Jones, Brian .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (31) :5278-5286
[3]   High-dose intrathecal trastuzumab for leptomeningeal metastases secondary to HER-2 overexpressing breast cancer [J].
Mir, O. ;
Ropert, S. ;
Alexandre, J. ;
Lemare, F. ;
Goldwasser, F. .
ANNALS OF ONCOLOGY, 2008, 19 (11) :1978-U13
[4]   Trastuzumab in CSF [J].
Pestalozzi, BC ;
Brignoli, S .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (11) :2350-2351
[5]   FcRn: the neonatal Fc receptor comes of age [J].
Roopenian, Derry C. ;
Akilesh, Shreeram .
NATURE REVIEWS IMMUNOLOGY, 2007, 7 (09) :715-725
[6]   Ranibizumab for neovascular age-related macular degeneration [J].
Rosenfeld, Philip J. ;
Brown, David M. ;
Heier, Jeffrey S. ;
Boyer, David S. ;
Kaiser, Peter K. ;
Chung, Carol Y. ;
Kim, Robert Y. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14) :1419-1431
[7]   Maximum tolerated dose of a humanized anti-vascular endothelial growth factor antibody fragment for treating neovascular age-related macular degeneration [J].
Rosenfeld, PJ ;
Schwartz, SD ;
Blumenkranz, MS ;
Miller, JW ;
Haller, JA ;
Reimann, JD ;
Greene, WL ;
Shams, N .
OPHTHALMOLOGY, 2005, 112 (06) :1048-1053
[8]   Safety and pharmacokinetic analysis of methotrexate administered directly into the fourth ventricle in a piglet model [J].
Sandberg, David I. ;
Solano, Juan ;
Petito, Carol K. ;
Mian, Abdul ;
Mou, Caihong ;
Koru-Sengul, Tulay ;
Gonzalez-Brito, Manuel ;
Padgett, Kyle R. ;
Luqman, Ali ;
Buitrago, Juan Carlos ;
Alam, Farid ;
Wilkerson, Jerome R. ;
Crandall, Kenneth M. ;
Kuluz, John W. .
JOURNAL OF NEURO-ONCOLOGY, 2010, 100 (03) :397-406
[9]   Pharmacokinetic analysis of etoposide distribution after administration directly into the fourth ventricle in a piglet model [J].
Sandberg, David I. ;
Crandall, Kenneth M. ;
Koru-Sengul, Tulay ;
Padgett, Kyle R. ;
Landrum, John ;
Babino, Darwin ;
Petito, Carol K. ;
Solano, Juan ;
Gonzalez-Brito, Manuel ;
Kuluz, John W. .
JOURNAL OF NEURO-ONCOLOGY, 2010, 97 (01) :25-32
[10]   Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. [J].
Slamon, DJ ;
Leyland-Jones, B ;
Shak, S ;
Fuchs, H ;
Paton, V ;
Bajamonde, A ;
Fleming, T ;
Eiermann, W ;
Wolter, J ;
Pegram, M ;
Baselga, J ;
Norton, L .
NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (11) :783-792